How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,301 results for

Emergency Medicine Treatment and Labor Act


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. The enduring role of the Emergency Medical Treatment and Active Labor Act. Full Text available with Trip Pro

The enduring role of the Emergency Medical Treatment and Active Labor Act. The Emergency Medical Treatment and Active Labor Act (EMTALA) is a seminal law that imposes screening, stabilization, and transfer duties on all Medicare-participating hospitals that have emergency departments. More than twenty-five years after its enactment, EMTALA continues to generate controversy over the scope and depth of its obligations on issues ranging from the nature of the screening obligation and rules (...) regarding on-call specialists to whether EMTALA's stabilization protections exclude emergency inpatients. Despite ongoing questions that flow from its detailed provisions, EMTALA is an enduring testament to society's evolving views that hospitals must provide emergency care not only to their established patients but to the broader communities they serve.

2013 Health affairs

22. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum

. | | Previous perinatal episodes of illness in the women and family history of severe perinatal episodes. | | The woman’ s treatment history including her responses and tolerability to medication, talking therapy and other interventions and her experience of them. | | Past episodes of self-harm, suicide attempts and risks to others. | | Duration of remissions on and off medication. | | Social functioning. | | Time to relapse after previous discontinuation. | | Time to recovery on reintroduction (...) of Pharmaceutical Science, King’s College London, London, UK 25 Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK 26 University of Manchester, Manchester, UK 27 UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK 28 Institute of Genetic Medicine, Newcastle University, Newcastle, UK Corresponding author: R H McAllister-Williams, Academic Psychiatry, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL

2017 British Association for Psychopharmacology

23. Does The Emergency Medical Treatment and Labor Act Affect Emergency Department Use? (Abstract)

Does The Emergency Medical Treatment and Labor Act Affect Emergency Department Use? Emergency departments (EDs) face increasing patient volumes and economic pressures. These problems have been attributed to the Emergency Medical Treatment and Labor Act (EMTALA).To determine whether modifying EMTALA might reduce ED use.We surveyed ED patients to assess their knowledge of hospitals' obligations to treat all patients regardless of insurance and to determine whether knowledge is associated with ED

2012 Journal of Emergency Medicine

24. Routine psychosocial care in infertility and medically assisted reproduction ? A guide for fertility staff

for a healthy experience of treatment Risk factors Valid assessment tools Psychosocial care that DOES NOT REQUIRE - Presence of mental health professionals - Specialized training 8 For instance, medical doctors usually provide information about treatment to patients and can use validated interventions. Administrative personnel usually deal with bureaucratic issues and can use the tools described in Appendix 2 for service user evaluation. Interventions that can only be delivered by mental health (...) -566. Dancet EA, Nelen WL, Sermeus W, De Leeuw L, Kremer JA, D'Hooghe TM. The patients' perspective on fertility care: a systematic review. Hum Reprod Update 2010;16: 467-487. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196: 129-136. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol 2012;30: 1178-1186. Gameiro S, Boivin J, Domar A. Optimal in vitro fertilization in 2020 should reduce treatment burden and enhance care

2015 European Society of Human Reproduction and Embryology

25. Preventing and Managing Infectious Diseases Among People who Inject Drugs in Ontario

who inject drugs o This element could include efforts to prevent or help people to stop injecting drugs, efforts to reduce the risk of infection (e.g., needle-exchange programs, safe consumption/injection sites, and opioid analgesic therapy) and enhancing education efforts for people who inject drugs (e.g., to minimize risk of infectious diseases, identify early symptoms of infectious diseases, and know where to seek treatment when needed). o Generally, the evidence for this element supported (...) >> Insight >> Action REPORT Injection drug use (IDU) has emerged as not only a pressing issue in Ontario given the spike in the overdose rate,(1) but also as a highly complex issue, given the need for coordinated responses that include those providing: • services and supports that reduce risk among people who inject drugs (PWID) (e.g., to prevent overdoses as well as the transmission of infectious diseases); • medical care (e.g., critical/emergency care providers and surgeons for treating life

2019 McMaster Health Forum

26. Workforce recruitment and retention: alcohol and other drug services

DRUG SERVICES | SAX INSTITUTE 5 Executive summary Background The aim of this review is to increase knowledge and understanding of evidence-based approaches that will enable the identification of key strategies to support the recruitment and retention of a skilled Alcohol and Other Drug (AOD) workforce. This review was prepared by Kylie Bailey and Julia Dray with contribution by Eliza Skelton and Mark McEvoy, from the School of Medicine and Public Health, The University of Newcastle. In 2012 (...) planning for the NSW health workforce. The NSW AOD workforce is composed of: AOD workers, nurses, social workers, doctors, peer workers, needle and syringe program workers, prevention workers, addiction medicine specialists, specialist psychologists, psychiatrists, and Aboriginal Health Workers. Due to an ever- complex workforce, unique barriers exist when planning for recruitment and retention of AOD health professionals. Alcohol and other drug recruitment and retention barriers Barriers

2020 Sax Institute Evidence Check

27. Interagency Guideline for Prescribing Opioids for Pain Agency Medical Directors' Group (AMDG)

for Chronic Non- cancer Pain Opioids in the Chronic Phase (>12 weeks after an episode of pain or surgery) Managing chronic pain and providing appropriate opioid therapy is a challenging aspect of both primary care and specialty care practices. This is why it is critical for providers to be very conscious of the risks and intentional about the treatment plan when prescribing these drugs. The key to effective COAT is sustained improvement in physical function and pain with frequent monitoring to adjust (...) . Repeat random UDTs at the frequency determined by the patient’s risk category to identify aberrant behavior, undisclosed drug use and/or abuse and verify compliance with treatment (Appendix D: Urine Drug Testing for Monitoring Opioid Therapy). d. Monitor for opioid-related adverse outcomes such as central sleep apnea, endocrine dysfunction, opioid-induced hyperalgesia, opioid use disorder or signs of acute toxicity. Be especially cautious with comorbid conditions that may increase risk for adverse

2015 Washington State Department of Labor and Industries

28. Systematic review of needs for medical devices for ageing populations

Systematic review of needs for medical devices for ageing populations Systematic review of needs for medical devices for ageing populations Commissioned to the Australian Safety and Ef? cacy Register of New Interventional Procedures – Surgical (ASERNIP-S) by the World Health Organization (WHO) Department of Essential Medicines and Health Products World Health Organization 20 Avenue Appia CH-1211 Geneva 27 Switzerland Tel: +41 22 791 21 11 E-mail: (...) ) and was prepared under the primary authorship of the Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S) group of the Royal Australasian College of Surgeons. Funding for this project was provided by the Japanese Ministry of Health, Labour and Welfare. The aim of this project was to produce a report in the form of a systematic review for WHO on needs for medical devices for older people for five main health conditions and 19 specific topics. This report was produced

2015 Publication 80

29. Biologic Therapies for Treatment of Asthma Associated with Type 2 Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks

also like to thank Aqsa Mugal, Ariel Jurmain, Milon Waththuhewa, Laura Cianciolo, and Madeline O’Grady for their contributions to this report.©Institute for Clinical and Economic Review, 2018 Page iii Final Evidence Report – Biologic Therapies for Treatment of Asthma About ICER The Institute for Clinical and Economic Review (ICER) is an independent non-profit research organization that evaluates medical evidence and convenes public deliberative bodies to help stakeholders interpret and apply (...) :// The findings contained within this report are current as of the date of publication. Readers should be aware that new evidence may emerge following the publication of this report that could potentially influence the results. ICER may revisit its analyses in a formal update to this report in the future. ©Institute for Clinical and Economic Review, 2018 Page iv Final Evidence Report – Biologic Therapies for Treatment of Asthma In the development of this report

2018 California Technology Assessment Forum

30. 12?step programs for reducing illicit drug use Full Text available with Trip Pro

and economic costs of illicit drug use motivate the strong political interest in treatment for illicit drug use and in identifying effective treatments. The main types of treatment are cognitive‐behavioural therapies, motivational enhancement, contingency management, psychoanalysis, network therapy and – the object of this review –12‐step programs (Galanter & Kleber, 2008). 1.2 DESCRIPTION OF THE INTERVENTION 12‐step approaches to the treatment of drug use are widespread in many countries. The oldest (...) enhancement therapy, relapse prevention). They concluded that 12‐step approaches were as effective as alternative approaches in terms of improving drinking consequences, and reduction of alcohol consumption. Ferri and colleagues did not explicitly exclude co‐dependence on illicit drugs, nor did they report whether participants, in the eighttrials that were included in the review, had comorbid substance dependence. Treatment effectiveness for comorbid participants treated for alcohol disorder might inform

2017 Campbell Collaboration

31. Medical Management of First-Trimester Abortion

other potential medical applications, including emergency contraception; cervical ripening and labor induction; and treatment of symptomatic uterine leiomyomas, endometriosis, Cushing syndrome, breast cancer, early pregnancy loss, and glaucoma ( , ). Misoprostol Misoprostol is an inexpensive prostaglandin E 1 analogue in a tablet form that is stable at room temperature. It is approved by the U.S. Food and Drug Administration (FDA) for oral administration to prevent gastric ulcers in individuals who (...) take antiinflammatory drugs on a long-term basis, and it is included in the FDA-approved labeling of mifepristone for use in abortion. It is used off-label in other regimens for abortion, labor induction, treatment of early pregnancy loss, prevention and treatment of postpartum hemorrhage, and cervical priming before uterine procedures, such as hysteroscopy ( ). Pharmacokinetic evaluations of misoprostol absorption when administered by various routes have been performed ( ). Routes that result

2014 American College of Obstetricians and Gynecologists

32. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

. Because most of the patients with PAH also had poor metabolic control, achieving good meta- bolic control may prevent PAH. If PAH is detected, pursuing effective treatment methods such as treatment with Bosentan and Sildenafil in consultation with a physician experienced in managing PAH is recommended. GENERAL MEDICAL CARE All patients with GSD should have a primary-care provider (“medical home”) specializing in pediatrics, adolescent, or internal medicine depending on the patient’s age (Box 7 (...) storage disease type I (GSD I) after reviewing the autopsy reports of two children whose livers and kidneys contained excessive amounts of Submitted 12 August 2014; accepted 12 August 2014; advance online publication 6 November 2014. doi:10.1038/gim.2014.128 Genet Med 00 00 2014 Genetics in Medicine 10.1038/gim.2014.128 ACMG Standards and Guidelines 00 00 12August2014 12August2014 © American College of Medical Genetics and Genomics 6November2014 Purpose: Glycogen storage disease type I (GSD I

2014 American College of Medical Genetics and Genomics

33. Physical Therapy Evaluation and Treatment After Concussion/Mild Traumatic Brain Injury

to using irritability to guide physical therapy treatments for individuals who have experienced a concussive event. 1 CPG Rationale Over the last decade, numerous concussion evidence-based CPGs, consensus statements, and clinical guidance docu- ments have been published. 19,34,61,141,149,153,159,160 These docu- ments have typically focused on the diagnosis of concussion and medical management of individuals post concussion, but provide little specific guidance for physical therapy manage - ment (...) Physical Therapy Evaluation and Treatment After Concussion/Mild Traumatic Brain Injury Clinical Practice Guidelines CATHERINE C. QUATMAN-YATES, PT , DPT , PhD • AIRELLE HUNTER-GIORDANO, PT , DPT KATHY K. SHIMAMURA, PT , DPT , NCS, OCS, CSCS, FAAOMPT • ROB LANDEL, PT , DPT , FAPTA BARA A. ALSALAHEEN, PT , PhD • TIMOTHY A. HANKE, PT , PhD • KAREN L. McCULLOCH, PT , PhD, FAPTA Physical Therapy Evaluation and Treatment After Concussion/ Mild Traumatic Brain Injury Clinical Practice Guidelines

2020 The Orthopaedic Section of the American Physical Therapy Association (APTA), Inc.

34. Short-acting ß2 agonists: restricted use for tocolysis in premature labour

2013 Salbutamol and terbutaline are short-acting β2 agonists (SABAs) with the obstetric indication of inhibition of premature labour. They are available in various formulations in the UK, including oral tablets, oral solutions, and parenterals (solutions for injection). In some European countries, these SABAs are also indicated at minimum doses and short duration of use for external cephalic version or emergency use in specified conditions. However, these are not licensed indications in the UK (...) Short-acting ß2 agonists: restricted use for tocolysis in premature labour Short-acting β2 agonists: restricted use for tocolysis in premature labour - GOV.UK GOV.UK uses cookies to make the site simpler. or Search Short-acting β2 agonists: restricted use for tocolysis in premature labour Use has been restricted to 48 hours’ maximum parenteral use under specialist supervision, after a European safety review. Published 11 December 2014 From: Therapeutic area: , Contents Article date: November

2013 MHRA Drug Safety Update

35. Qualitative evidence on barriers to and facilitators of women’s participation in higher or growing productivity and male-dominated labour market sectors in low- and middle-income countries

Economic Empowerment and prominence within the 2030 Agenda for Sustainable Development. 1 A wide range of factors hinder women’s participation in the labour market, especially in higher productivity sectors that are male-dominated. Many countries around the world, either with international donor support or in response to domestic economic policy compulsions, are changing laws, regulations and policies to address these barriers. A trans-disciplinary literature has emerged in recent years that reflects (...) Qualitative evidence on barriers to and facilitators of women’s participation in higher or growing productivity and male-dominated labour market sectors in low- and middle-income countries 1 Qualitative evidence on barriers to and facilitators of women’s participation in higher or growing productivity and male-dominated labour market sectors in low- and middle-income countries SYSTEMATIC REVIEW, APRIL 2019 i The authors of this report are: H Elizabeth Peters (Urban Institute, Washington, DC

2019 EPPI Centre

36. Emergency Medicine Treatment and Labor Act

Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Aka: Emergency Medicine Treatment and Labor Act , EMTALA From Related Chapters II. Background Emergency Medicine Treatment and Labor Act (EMTALA) was Enacted in U.S. in 1986 as part of COBRA Ensures access to emergency services regardless of ability to pay Applies to most hospitals in the United States (those that accept CMS payment) III. Criteria Includes an emergency medical screening to determine if a medical (...) Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4

2015 FP Notebook

37. Does Mednav, a Medical Navigation System, Aid Non-technical and Technical Skills in the Simulated Obstetric Emergency?

been developed called 'Mednav'. Mednav is a navigation device for the management of medical emergencies; developed at Chelsea and Westminster Hospital since 2010. This is a device which acts similar to a satellite navigation devices in the automobile industry navigating you from A to B, MedNav navigates the clinician from the unwell patient to the well patient. Condition or disease Intervention/treatment Phase Postpartum Hemorrhage, Device: MedNav Not Applicable Detailed Description: Potential (...) Posted : May 26, 2016 Last Update Posted : May 26, 2016 Sponsor: Chelsea and Westminster NHS Foundation Trust Information provided by (Responsible Party): Chelsea and Westminster NHS Foundation Trust Study Details Study Description Go to Brief Summary: It is well known that medical errors account for a large amount of patient harm within the hospital setting. This is a significant problem within the emergency context. A system that acts as a prompt, guide and scribe for the obstetric emergency has

2016 Clinical Trials

38. Guidelines for the Administration of Electroconvulsive Therapy

that electroconvulsive therapy is a continually evolving practice. Conclusion: The guidelines provide up-to-date advice for psychiatrists to promote optimal standards of electroconvul- sive therapy practice. Keywords Guidelines, electroconvulsive therapy, monitoring, depressive disorders, schizophrenia 1 School of Medicine and Public Health, Faculty of Health and Medicine, The University of Newcastle, Australia, Callaghan, NSW, Australia 2 School of Psychiatry, Faculty of Health and Medical Sciences, The University (...) , 2013), and for the treatment of agitation and aggression in patients with dementia (Glass et al., 2017; Isserles et al., 2017; Manjola, 2015), though should only occur in these circumstances and for other emerging indica- tions in consultation with a psychiatrist with expertise in the use of ECT for such indications. There is also potential application of ECT in the treatment of severe Parkinsonism not responsive to medication with the on–off phenomenon and the occasional use of ECT for intractable

2019 American Psychiatric Association

39. Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives

, and Industry Incentives Enabling Legislation Criteria for Orphan Drug Designation Incentives for Pharmaceutical Industry US FDA Orphan Drug Act 1983 (and 1984, 1985, 1988, 1992 amendments The drug (expanded to include biologics, medical devices, medical foods) is indicated for treatment, diagnosis, or prevention of a disease or condition affecting fewer than 200,000 people in the US at the time of the orphan drug designation submission; or affects more than 200,000 people in the US but costs of developing (...) ; no satisfactory method of diagnosis, prevention or treatment of the condition concerned can be authorised, or, if such a method exists, the medicine must be of significant benefit to those affected by the condition.” 2 Japan’s Ministry of Health, Labour and Welfare “The number of patients who may use the drug should be less than 50,000 in Japan. The drugs should be indicated for the treatment of serious diseases, including difficult-to-treat diseases. In addition, they must be drugs for which there are high

2016 Canadian Agency for Drugs and Technologies in Health - Environmental Scanning

40. 2018 IDSA Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy

appropriately early in treatment. The selected antimicrobial agent should have activity against the identified or presumptive causative pathogen(s), known distribution to the site of infection, and proven therapeutic efficacy in the infection being treated. Patient factors that may impact efficacy must be considered, including comorbidities, concomitant therapies (drug and non-drug), patient age, and organ function. Programmable infusion pumps and elastomeric devices (disposable balloons that push (...) . It does not offer recommendations on the treatment of specific infections. The reader is referred to disease- or organism-specific guidelines for such support. Executive Summary Outpatient parenteral antimicrobial therapy (OPAT) is defined as the administration of parenteral antimicrobial therapy in at least 2 doses on different days without intervening hospitalization. Recommendations made in the updated guideline for the prescription and management of OPAT are summarized below. The panel followed

2018 Infectious Diseases Society of America

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>